跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HIF-1 inhibitors (cancer)
首页
药物
HIF-1 inhibitors (cancer)
HIF-1 inhibitors (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Controlled release formulations for the delivery of HIF-1 inhibitors
申请人: UNIV JOHNS HOPKINS
优先权: 2013
US
4 件公开
Thiophene derivatives
申请人: MERCK PATENT GMBH
优先权: 2018
CN
US
2 件公开
Compounds as HIF-1alphainhibitors and manufacturing process thereof
申请人: UNIV DONGGUK IND ACAD COOP
优先权: 2011
US
2 件公开
MN/CA IX and MAPK inhibition
申请人: PASTOREKOVA SILVIA
优先权: 2007
US
Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses
申请人: UNIV DUKE
优先权: 2010
US
Inhibition of HIF-1 activation for Anti-Tumor and Anti-Inflammatory responses
申请人: DEWHIRST MARK W
优先权: 2011
US
CONDENSED THIOPHENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR (HIF) INHIBITORS
申请人: MERCK PATENT GMBH
优先权: 2019
WO
DIRECT-BINDING DUAL INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR 1 (HIF-1) AND HIF-2
申请人: UNIV JOHNS HOPKINS
优先权: 2024
WO
药物
反馈